Fujifilm Holdings Corp. proposed a partnership Monday with Olympus Corp., the camera and endoscope maker that lost more than half of its market value last year amid an accounting scandal. Fujifilm, which makes imaging equipment and digital cameras, may invest … Continue reading →
Categories: Ideas For Surgery News |
Tags: 2012 California Biomedical Industry Report , Academic and regional medical facilities , accelerated investments to serve the emerging markets , accelerating globalization , Access to capital , acquisition of technologies , acroMIS Consulting , acromis implementation and development , address patients’ need , address the high risk , adoption of austerity measures , advantageous position , adverse impact on technology , age-related disease , Akio Nakagawa , Altis , Altis and Humalabo , Amigo teleoperated catheter steering system , angel investors , aortobifemoral bypass , aortoiliac occlusive disease , applications in laparoscopic vascular and endovascular surgery , Applications in laparoscopic vascular surgery , around the globe , Artisan Extend Control Catheter , availability of capital to fund future innovation , AXAM , AXAM Investments Inc. , Axes , Axes America LLC , Axes America’s President and CEO , Axes Investment Management Co. , Axes Securities , Axes Securities Co , bankrupt , BayBio , biggest long-term opportunity , Biomedical Access to Capital , biomedical cluster , biomedical company CEOs , biomedical innovation , biotechnology , Board Relations , Boston Consulting Group , British medical company Gyrus , burdensome and uncertain regulatory environment , business in financial transactions , Business Valuation , California Biomedical Industry 2012 Report , California companies are adaptive and resourceful , California Healthcare Institute , California’s biomedical industry , Candidates in queue , cardiac interventions , CARDIODRIVE Catheter Advancement System , Catheter Robotics , Cayman Islands , CE Mark trial of the next-generation , CEO of ITX , challenging environment , CHI-California Healthcare Institute , choosing the right delivery method , clinical applications of robotics in laparoscopic vascular and endovascular surgery , Clinical Development , clinical outcomes of geographic miss and stent misplacement , clinical robotic applications in vascular surgery , clinical studies , clinical value , close proximity of monitors , CoHesion 3D Visualization Module , Collaboration and capitation strategies , Comfortable seating position , commercialize medtech , Comparative Cost Effectiveness , comparative effectiveness data CED , competitive landscape is likely to change , compounding investors’ apprehensions , computer assisted surgery , congestive heart failure , Congress , considered as a first line therapy , constitutional challenges to healthcare reform legislation , constrained coverage and payment for innovative products , constrained healthcare budgets , control contrast injection , conventional catheterization systems , conventional treatments , Corindus , CorPath 200 System , corporate finance , corporate partnerships as a source of financing , corporate venture capital as a finance source , Corporate venture funding , Cost reduction and value creation , Cost vs Value , cost-effective solutions , countries with more certain regulatory pathways , coverage and reimbursement issues are extremely important , critical decision factor , current global economic situation , cyclical problem of depressed macroeconomic conditions , da Vinci surgical system , Dashboard and Scorecards , Dashboards and Scorecards , dealing with high risk complications , declining performance at the FDA , declining procedure volume , delay a research or development project , deliver value to the overall healthcare system , delivered through two approaches , delivering better economic value , demonstrate the economic value at both the provider and payer levels , develop specific plans to accelerate our global growth , devices approved for procedures , devices are priced at a hefty premium , diagnostics or medical equipment , disease foundations/non-governmental organizations , dispute , disruptive business models , dormant , Drexel , Drexel Burnham Lambert , Dynamic Dragons , each of the major emerging markets , early clinical reports , easier access to capital , economic downturn , economic potential of this specialized , electrocardiography monitors , electronic direct dosimeters (EDD-30) , emerging markets , Emerging robotic technologies , Emerging Technology Evaluation , enabling better concentration and focus , endovascular , endovascular repair of abdominal aortic aneurysm , endovascular robot , engaging primarily with the physician , enhance the precision of cardiovascular procedures , Enhanced visualization and measurement capability , enrollment in the pilot study , EnSite System , establishment of healthcare insurance exchanges , evaluate the advantages of robot-assisted vascular procedures , evaluated the merits of our products solely on the clinical value , Evolving Market , expanding insights into these markets , expanding markets , expansion of its applications , factors have discouraged investments in biotech and device startups , FDA has the best regulatory approval process in the world , federal efforts to contain the escalation of Medicare spending , Financial Modeling , Findings of the CEO Survey , FINRA records , first mover advantage , fluoroscopy monitors , focus on emerging markets , for Endovascular Teleoperated Access (SETA) , force the players to increasingly compete on price , forced to look for other solutions , Forty-four percent of biomedical CEOs surveyed said they will look to licensing agreements , from a console remote from the operating table , G.C. Venture Capital , Global Chef , Global Company , Global Company’s CEO Yokoo Nobumasa had also been CEO of Humalabo’s predecessor company L.E.M. Hanbai , global growth goals , global leadership position , global P&L responsibility , government grants , government initiatives , great expansion of Medicaid to cover the uninsured , growth opportunity for our industry , guidewire and balloon/stent devices , Gyrus deal , Haio Fauser is a local market expert in each of the geographic regions , Hajime “Jim” Sagawa , Hajime Sagawa , Hamada Masayuki , Hansen Medical , Hayashi Masayuki , hemodynamic monitors , hide losses , high surgical risk , Hirata Kiichi , Humalabo , Ichimura Takuya , Implantable medical devices IMD , Implementation , Implementation of the Affordable Care Act , Improved control of contrast injection , Improves visualization of angiography , improving our ability to attract investment and grow , In the face of these challenges , in the OUS market , inconsistent communications , increased pressure in utilization , increasing pressure on drug and device margins , independent investigation from the company’s top institutional shareholders , Independent Medicare Payment Advisory Board , informal capacity , Innovation , innovation and state-of-the-art medical technology , innovative technologies , IntelliSense Fine Force Technology , Interventional lead-lined cockpit , Intraluminal , investigations from government , Investment firm , Investment Management , issues being discussed throughout the biomedical industry by executives , J Alternative , J Bridge/Asia Alliance Holdings , Japanese camera maker Olympus , job creation , Joint Ventures , Kawada Hitoshi , Key Opinion Leader Connections , key opinion leader KOL , Kobe University in Economics , KOL Physicians , Kosaka Kiyoshi , Lack of funding , lack of innovation and productivity , laparoscopic vascular and endovascular capabilities , laparoscopic vascular and endovascular treatments , leadership position , left ventricular ejection fraction , less invasive treatment , licensing agreements , looking beyond California’s and our nation’s borders , lower extremity arterial disease , Ltd. , M&A deal , maintain the high standards of safety and effectiveness , major adverse cardiac event (MACE) , major California venture capital firms , maker of microwavable plastic , manipulating the guidewire , many patients with age working against them , market in Europe , Marketing , Masayuki Hamada , massive decline in Olympus stock price , Matsumoto Kuniaki , Medical , Medical device , medical device industry , medical device innovation , Medical devices , medical devices companies , Medical Facilities , Medical technology , MedTech , meet the urgent need of patients , meeting the needs of the billions of people in emerging markets , Mergers & Acquisitions , Merrill Lynch , Michael Woodford , Minimal comparative clinical evidence , minimizes head neck and back pain , modality for abdominal aortic aneurysm repair , Mori Hisashi , moved out of investing in life sciences companies , multinational , Murata Masami , myocardial ischemia , myriad of complications , mysterious payment , Nakagawa Akio , nascent technologies , necessity of the procedures to be performed in specialized centers , Neo Strategic Venture LP , Neuro/ spine , New Investments Ltd. , new law being implemented with direct consequences for the biomedical industry , new medical devices , new taxes on drug and devices , News Chef , NIOBE magnets , Nishihata Youhei , Nishimori Hitoshi , Nissho Iwai , Nobel Prize winning economist , Nomura , Nomura Securities , noninvasive , obscure , obstructive coronary artery disease , oly $2 billion acquisition , Olympus Executive Vice President , onditions , Open architecture system , Operating room , Operational assessment , Optimize Innovation And Accelerate Globalization , Optimized ergonomics , OR efficiencies solutions , outside the US OUS , Outside The USA (OUS) Global Markets Amid Soft US Sales , overt risk , Paine Webber , PaineWebber , paradigm-changing , partnerships , percutaneous coronary intervention (PCI) , Percutaneous or surgical , Performance vs Targets , Perioperative health care technologies , pharmaceuticals , Physician Preference Items PPI , physicians may have to perform 30 cases before they attain the desired level of proficiency , physicians’ learning curve , pivotal trial , placement of guidewire and catheter , planned coronary artery bypass graft surgery , Portfolio Management , Precise robotic movement , preclinical evidence , preclinical studies , prevailing economic uncertainty , PricewaterhouseCoopers (PwC) , principle investigator , Product Development , products in clinical development , progressive , project delays cited by private company CEOs , Proof-of-concept Lab Trials , proper selection of patients , prospective studies , providing expertise. early clinical evidence , proximal aortic anastomosis , PwC , R&D , radiation dose for the patient , Radiation protection , raising concerns about coverage and payment for medical technologies , rapid exchange catheter systems , recent launches , recreate the ecosystem that has made the US the leading biomedical region , reduced radiation zone for the physician , Reduces fatigue , regions with financial incentives , regions with financial incentives and easier access to capital , regulatory and reimbursement processes , regulatory changes , Regulatory Environment will Determine R&D Productivity , regulatory framework that is based on consistency , Regulatory risk at the US Food and Drug Administration , reimbursement pressure , remote device manipulation system , remotely direct the catheter tip , renal aortic pathologies , representatives on their staff from each region , resources , restructuring initiatives , Retrospective evaluation study of lens injuries and dose (RELID) , review our businesses , Robert Mundell , Robot-assisted intervention , Robot-assisted laparoscopic aortic procedures , robot-assisted laparoscopic aortic surgery , robotic computer-enhanced telemanipulation systems , Robotic PCI system , robotic surgery , robotic technology , Robotic-Assisted Coronary Angioplasty System , Robotically steerable endovascular catheter systems , robotics , Sagawa & Company , Sagawa Capital , Sagawa International Services , Sanyo Securities America , Sato Hideki , scheduled for completion , seeking diverse funding sources , Services to hospital leaders , shareholders , sharply reduced their asset allocations , slower growth of US markets , snapshot of the biomedical industry in California , Sojitz , solutions that deliver better economic value , source of funding to the industry , special-purpose investment vehicles , splenic and renal artery aneurysm reconstruction , stable device deployment , standard catheterization laboratory hardware and imaging systems , state-of-the-art procedure , steerable catheter , Stent deployment Techniques on cLinicaL outcomes of patients treated with the cypheRstent (STLLR) , Sterotaxis , Strategic Planning , Strategy Development , strong and collaborative partnership between our business , surgical robotics , Surgical supplies cost reduction , sustainable growth , System and process focused , Tactical Execution of Commercialization Programs , Tactile Vibration interface , Takahashi Yoshinori , Tanabe Souhei/Shouhei , targeting a limited launch , tax incentives for innovation , Team work , Techno Mining Ltd. , Technological innovations , teleoperated system for steering interventional devices , The CEO Survey , the continuing healthcare cost crunch , the current FDA regulatory approval process has slowed the growth , the current trajectory of rising healthcare costs is unsustainable , the future of global economic recovery , the investment of corporate funds into external endeavors , the standard of care , threats to the biomedical industry’s growth , three major areas reflecting government policy , to countries with more certain regulatory pathways , To Improve Execution , top executive , training of the physicians and staff is significant , transmission of the operator’s movements , two mysterious sets of corporate deals , UBS AG , unclear standards for what clinical data are necessary for product approval , Under development , unexplained regulatory delays , unfavorable reimbursement decision from the CMS , Unfors Billdal Sweden , unsuitable for this open surgery , US medical device start-up companies , Value Analysis , Value-based health care , vascular surgery , vasculature , visualization of angiography , Wasserstein Perella & Co. , we must prioritize our investment , Web-based search engines , widespread economic uncertainty , Widespread rollout , Working collaboratively with other stakeholders , www.axesim.co.jp , Yokoo Akinobu , Yokoo Nobumasa , Yoshida Minoru , Yoshikai Ryuzo , Zeus robotic system |
Permalink
